1 Min Read
April 6 (Reuters) - Pfizer Canada Inc:
* PFIZER CANADA SAYS BESPONSA APPROVED BY HEALTH CANADA FOR TREATING ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.